Hologic, Inc.’s HOLX Diagnostics segment, excluding COVID-19 assay and related revenues, is expected to have significantly ...

On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a ...

周一，Hologic (NASDAQ: HOLX) 确认了以3.5亿美元收购位于加利福尼亚州红木城的私人公司Gynesonics的计划。此次收购旨在通过添加Sonata系统（一种用于治疗子宫肌瘤的设备）来增强Hologic在妇科手术市场的产品组合。 Sonata系统以其创新的肌瘤消融方法而闻名，结合了SMART超声引导和射频能量。这项技术能够在不需要切口的情况下治疗各种类型的肌瘤，并且通常允许患者 ...

RBC Capital analyst Conor McNamara maintained a Hold rating on Hologic (HOLX – Research Report) on October 23 and set a price target of ...

Hologic, Inc. HOLX GYN Surgical is expected to have registered vital contributions from MyoSure and the Related fluid system, with an increasing contribution from its laparoscopic portfolio.

Hologic’s MyoSure device/procedure is also a solution for fibroid removal, though this is done through tissue removal rather than tissue ablation. “We believe that while there could become ...

Morgan Stanley analyst Tejas Savant maintained a Hold rating on Hologic (HOLX – Research Report) today and set a price target of $84.00.

Hologic is asking women to #BustTheMyth this Breast Cancer Awareness Month. The provider of breast health products has put a set of myths about cancer, such as the belief women without a family ...

Growth in the GYN Surgical arm is expected to have been fueled by MyoSure and the related Fluent Fluid Management System. Hologic is also likely to have gained from its Laparoscopy business ...

Hologic (HOLX) closed at $79.77 in the latest trading session, marking a -0.98% move from the prior day. This move lagged the S&P 500's daily gain of 0.01%. Meanwhile, the Dow experienced a rise ...